Our customers' Feedback
Search:
Perform search
Categories list

Generic Viread

News
Viread
Viread photo

Generic Viread (Tenofovir Disoproxil Fumarate)

Antivirals, HIV

PackagePricePer PillSavingsOrder
300mg × 30 pills$149.95$5.00Add to cart
300mg × 60 pills$289.95$4.83$9.95Add to cart

Most popular quantity.
Ziagen
$ 6.00
Generic Ziagen
(Abacavir 300mg)
Zovirax
$ 0.64
Generic Zovirax
(Acyclovir 200/400/800mg)
Atripla
$ 324.98
Generic Atripla
(Efavirenz+emtricitabine+tenofovir 600mg + 200mg + 300mg 30 /600mg + 200mg + 300mg 30 pills)
Combivir
$ 1.44
Generic Combivir
(Lamivudine - Zidovudine 150mg + 300mg)
Crixivan
$ 5.20
Generic Crixivan
(Indinavir 400mg)
Efavirenz
$ 0.00
Generic Efavirenz
(Efavirenz 200/500/600mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • China Drug Deal Will Slash Prices of Three Top-Selling Treatments - Wall Street Journal

    Wall Street JournalChina Drug Deal Will Slash Prices of Three Top-Selling TreatmentsWall Street JournalThe monthly price of Iressa would fall 55% to 7,000 yuan ($1,070), Viread would drop 67% to 490 yuan ($75) and Conmana would decline 54% to 5,500 yuan ($840).

  • Biotech, foreign companies, China - Seeking Alpha

    Biotech, foreign companies, ChinaSeeking AlphaShanghai Fosun Pharma (SHA: 600196; HK: 2196) has submitted a non-binding bid to acquire India's Gland Pharma, a contract manufacturer of injectible drugs.

  • Pharmalot, Pharmalittle: Roche fumes as UK watchdog rejects a drug over cost - STAT

    STATPharmalot, Pharmalittle: Roche fumes as UK watchdog rejects a drug over costSTATThe National Health and Family Planning Commission said prices will drop for GlaxoSmithKline's Viread hepatitis B drug and AstraZeneca's lung cancer pill Iressa, along with a lung cancer drug made by China's Betta Pharmaceuticals.

  • ETF Preview: ETFs, Futures Higher as Worries Over Interest Rate Hike Fade; Existing Home Sales Data Still Ahead - Nasdaq

    ETF Preview: ETFs, Futures Higher as Worries Over Interest Rate Hike Fade; Existing Home Sales Data Still AheadNasdaqThe commission said the cost of GlaxoSmithKline's hepatitis drug B drug Viread will fall to 490 yuan ($75) per month from 1,500 yuan, while the price of AstraZeneca's lung cancer pill Iressa will be lowered to 7,000 yuan from 15,000 yuan, Reuters said.

  • Gilead Has Great Value Now; No Need For It To Make A Big Deal - Seeking Alpha

    Smarter AnalystGilead Has Great Value Now; No Need For It To Make A Big DealSeeking AlphaBut, as I show, it has made a number of tuck-in deals ranging from pre-clinical candidates up to a Phase 3-ready one, for 'real money' in aggregate.

    Copyright © cheapgenerics24.com